| Sex, male:female | 99:69 | 243:164 | 45:24 |
| Age (mon) | 7 (1–12) | 31 (13–60) | 72 (61–170) |
| Weight (Kg) | 8.4 (4.3–15.7) | 13.5 (7.2–24.8) | 21.7 (14.1–54.0) |
| Height (cm) | 70.0 (52.0–98.4) | 91.7 (68.0–122.3) | 115.4 (103.3–158.6) |
| Fever duration, total (day) | 5.5 (1–11)1)2) | 6.5 (2–19) | 6.6 (2–17) |
| Fever duration, prior to admission (day) | 4.0 (1–11) | 4.8 (1–17) | 4.9 (2–16) |
| Duration until fever subsided (hr) | 44.0 (3–178) | 50.7 (3–164) | 57.0 (13–121) |
| Hospitalization duration (day) | 5.3 (2–20) | 5.1 (2–30) | 5.2 (2–39) |
| Counts of diagnostic symptoms | 3.2 (0–5)1) | 3.6 (0–5) | 3.5 (1–5) |
| Conjunctival injection (%) | 137 (81.5) | 357 (87.7) | 59 (85.5) |
| Changes in lips/oral cavity (%) | 126 (75.0) | 328 (80.6) | 53 (76.8) |
| Change in extremities at acute phase (%) | 85 (50.6) | 237 (58.2)3) | 26 (37.7) |
| Polymorphous exanthema (%) | 122 (72.6) | 286 (70.3) | 42 (60.9) |
| Cervical lymphadenopathy (%) | 45 (26.8)1)2) | 230 (56.5)3) | 54 (78.3) |
| BCG inoculation site erythema (%) | 131 (78.0)1)2) | 90 (22.1)3) | 4 (5.8) |
| Perineal desquamation (%) | 4 (2.4)1)2) | 28 (6.9) | 6 (8.7) |
| Desquamation in extremities at subacute phase (%) | 61 (36.3)1) | 113 (27.8) | 23 (33.3) |
| Pyuria (%) | 54 (33.3)2) | 117 (29.0)3) | 11 (16.2) |